医脉通首页
软件中心
频道导航
资讯
病例
专题
圈子
指南
期刊文献
诊疗知识库
e信使
e讲堂
e调研
会议
医生工具
互助区
登录
注册
搜索词条
新版本
知识库首页
分类索引
我的知识库
急性冠脉综合征 -
推荐文献
概览
简介
名称与编码
精要
历史
致谢
缩略语表
基础
定义
流行病学
病因
病理解剖
病理生理
分类分型
预防
预防
筛检
诊断
问诊与查体
疾病演变
辅助检查
并发症
诊断标准
诊断程序
鉴别诊断
治疗
治疗目标
治疗细则
管理与监测
治疗程序
治疗进展
护理与照顾
随访
随访要点
预后
患者教育
临床资料
诊疗指南
临床路径
病例
临床问题
文献资料
参考文献
网络资源
推荐文献
课件
图片
聚合阅读>>
推荐文献
A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project.
Temporal Trends in the Characteristics, Treatment, and Outcomes of Conservatively Managed Patients With Non-ST Elevation Acute Coronary Syndrome (from the ACSIS Registry 2000 to 2016).
Skeletal Muscle ACSL Isoforms Relate to Measures of Fat Metabolism in Humans.
Ophthalmic Artery Morphological and Hemodynamic Features in Acute Coronary Syndrome.
[临床试验]Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.
[综述]Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF.
[临床试验]International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19.
P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
[比较研究]Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets.
Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.
[临床试验]High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial.
Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth.
[临床试验]Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome.
The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): third Paediatric (Paedi-EUROMACS) report.
[Meta分析]Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis.
Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome.
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP).
[临床试验]Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
统计信息
录入日期：2011-01-07
最近更新：2013-01-08
浏览次数：238355
编辑次数：219
我要参编
参编团队
主编
胡大一
主任医师
胡大一，男，主任医师、教授、博士生导师，美国心脏病学学会和欧洲心脏病学学会专科会
...
[详情]
主要编写者
廖华
副主任医师
热心编写者
更多>>
阿肖
周义
lutongqing
更多>>
知识库免责声明
本诊疗知识库所提供的有关疾病检查、诊断、治疗以及预防等所有信息，仅供医生参考和学习，不面向患者，不能代替任何医生的处方和医嘱。
如果你对诊疗知识库有任何建议和意见，请联系
010-64405225
。
关于我们
|
联系我们
|
隐私政策
|
版权声明
|
免责声明
|
公司产品
|
网站帮助
北京医脉互通公司 版权所有
（京）-非经营性-2018-0300
京公网安备
11010502036930
京ICP备
13043379
号-5
京ICP证
130463
号
©
2005-2025 medlive.cn, all rights reserved
